In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, explains with specific endpoints they'll be looking at in the Phase I trial to assess LP-284's potential efficacy a ...

PE: What are some of the unique challenges that CGT developers need to plan for and overcome when building their channel strategy? Lattanzi: Channel strategy is probably one of the most important ...

A Harvard Business School Healthcare Alumni Association Q&A with Dorie Clark, Instructor of Executive Education at the Columbia Business School.

From recruiting clinical trial participants, to engaging patients with their permission at the point of care, to creating brand lift and awareness, the marketing landscape for pharma presents both ...

Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs. AstraZeneca announced that it has officially completed its equity investment ...

Myhibbin is reportedly the first FDA-approved liquid formulation of mycophenolate, a key immunosuppressant used to prevent ...

Acceptance of the application was based on promising results from the Phase III CheckMate -67T study, which displayed ...

Premera Blue Cross announced that it has appointed Dr. Romilla Batra as senior vice president and chief medical officer. 1 In ...

Dr. Jonathan Lewin is the first surgeon in the state of New Jersey to use the PathKeeper Surgical Spinal Navigation System on ...

The founder and CEO of UpScriptHealth discusses the issues causing the shortage and how recent decisions from the DEA may help solve the issue.

In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, discusses how more granular insights into channel, tracing, and chargeback data can help ...

The catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter, and the Socrates 38, an aspiration catheter specifically designed for treating ischemic strokes.